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Helicobacter pylori (H. pylori) is a human gastric pathogen that has been linked to the
development of several gastric pathologies, such as gastritis, peptic ulcer, and gastric
cancer. In the gastric epithelium, the bacterium modifies many signaling pathways,
resulting in contradictory responses that favor both proliferation and apoptosis.
Consistent with such observations, H. pylori activates routes associated with cell cycle
progression and cell cycle arrest. H. pylori infection also induces the hypoxia-induced
factor HIF-1α, a transcription factor known to promote expression of genes that permit
metabolic adaptation to the hypoxic environment in tumors and angiogenesis. Recently,
however, also roles for HIF-1α in the repair of damaged DNA and inhibition of gene
expression were described. Here, we investigated signaling pathways induced by
H. pylori in gastric cells that favor HIF-1α expression and the consequences thereof
in infected cells. Our results revealed that H. pylori promoted PI3K/mTOR-dependent
HIF-1α induction, HIF-1α translocation to the nucleus, and activity as a transcription
factor as evidenced using a reporter assay. Surprisingly, however, transcription
of known HIF-1α effector genes evaluated by qPCR analysis, revealed either no
change (LDHA and GAPDH), statistically insignificant increases SLC2A1 (GLUT-1)
or greatly enhance transcription (VEGFA), but in an HIF-1α-independent manner, as
quantified by PCR analysis in cells with shRNA-mediated silencing of HIF-1α. Instead,
HIF-1α knockdown facilitated G1/S progression and increased Cyclin D1 protein
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half-life, via a post-translational pathway. Taken together, these findings link
H. pylori-induced PI3K-mTOR activation to HIF-1α induced G0/G1 cell cycle arrest by a
Cyclin D1-dependent mechanism. Thus, HIF-1α is identified here as a mediator between
survival and cell cycle arrest signaling activated by H. pylori infection.
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INTRODUCTION
Helicobacter pylori is a microaerophilic, Gram-negative
bacterium that colonizes the human stomach, infecting about
50% population worldwide (Peleteiro et al., 2014). This infection
is linked to the development of several gastric pathologies,
including chronic atrophic gastritis, gastric, and duodenal ulcer,
MALT lymphoma and gastric adenocarcinoma (Atherton, 2006;
Correa and Houghton, 2007). H. pylori infection contributes
to the etiology of these diseases by inducing seemingly
contradictory epithelial gastric cell responses, including
exacerbated apoptosis and proliferation. In conjunction, these
responses lead to disturbances in the normal turnover of
gastric epithelium (Jang and Kim, 2000), which favor atrophy, a
precursor lesion in the sequence of events leading to intestinal
metaplasia, dysplasia, and eventually cancer. Bearing this in
mind, it becomes important to understand better the underlying
molecular events that initiate such changes.
Consistent with the aforementioned ambiguity in host cell
responses, the bacteria activate signaling pathways linked to
cell cycle progression and therefore, proliferation, as well as
those that result in cell cycle arrest and H. pylori-induced
apoptosis (Shirin et al., 1999; Ahmed et al., 2000; Suzuki et al.,
2009; Tabassam et al., 2009). With respect to the signaling
events linked to H. pylori-induced cell cycle progression, the
PI3K/Akt pathway has received considerable attention. In the
context of infection, activation of this pathway is associated
with an increase in proliferation via induction of β-catenin/Tcf-
Lef-dependent transcription, cell survival, and cell migration, as
well as enhanced protein synthesis via mTOR activation (Nagy
et al., 2009; Suzuki et al., 2009; Sokolova et al., 2014). However,
despiteH. pylori-induced PI3K activation, the infection promotes
opposite effects in gastric cells, such as cell cycle arrest in G1
phase and apoptotic cell death (Shirin et al., 1999; Ahmed
et al., 2000) via mechanisms that may involve loss of Survivin
(Valenzuela et al., 2010, 2013) amongst others.
On the other hand, H. pylori also promotes the induction of
Hypoxia Inducible Factor 1α (HIF-1α), the inducible subunit of
the heterodimeric transcriptional factor HIF-1. Generally HIF-1
increases in hypoxia where it promotes the expression of genes
linked to several cell responses, including increased glycolytic
metabolism, angiogenesis, survival, and epithelial-mesenchymal
transition, all of which are important for tumor progression
(Semenza, 2012). As such, activation of HIF-1α is considered a
key step that favors malignant disease progression, also in gastric
cancer (Kitajima and Miyazaki, 2013). The canonical signaling
pathway controlling HIF-1α expression in normoxia involves the
hydroxylation on proline residues (Pro402 and Pro564 in human
HIF-1α) by proline hydroxylases and subsequent degradation via
the proteasome pathway. In hypoxia, lack of oxygen leads to
a decline in proline hydroxylase activity, reduced degradation
and as a consequence an increase in HIF-1α protein (Semenza,
2012). However, in addition to hypoxia, HIF-1α can be induced
by hypoxia-independent mechanisms involving activation of
tyrosine kinase receptors and the downstream PI3K/Akt/mTOR
and MEK/ERK pathways, as well as by the production of reactive
oxygen species (ROS) (Laughner et al., 2001; Fukuda et al.,
2002). Particularly H. pylori infection of the gastric epithelium
and ROS-mediated stabilization of HIF-1α have been suggested
to induce proliferation, inhibit cell death and ultimately favor
carcinogenesis in the gastric epithelium (Koshiji et al., 2005;
Kitajima and Miyazaki, 2013).
Although HIF-1α is induced by these pathways known to
favor tumor development and tumor progression, in more
recent years a non-transcriptional function for this protein that
contrasts with its canonical role has been described, whereby
the protein prevents cell cycle progression by blocking DNA
replication and modifying the expression of several proteins
involved in cell cycle control, which results in inhibition of
the G1/S transition (Goda et al., 2003; Koshiji et al., 2004;
Hubbi et al., 2013). Such non-transcriptional HIF-1α activity
has been reported in hypoxia, but it remained unknown
if this occurs in the context of HIF-1α induction by H.
pylori infection of gastric cells and what the consequences
might be.
Considering that H. pylori promotes both HIF-1α
induction and PI3K/Akt pathway activation, but also can
leads to cell cycle arrest, we hypothesized that HIF-1α may
serve as a molecular switch from proliferative signaling
towards cell cycle arrest in gastric cells infected with this
bacterium. In this study, we evaluated if H. pylori promoted
PI3K/Akt/mTOR activation, whether this increased HIF-1α
protein levels and whether this factor contributed to cell
cycle arrest mediated by H. pylori. Our results implicate
PI3K and mTOR activation in H. pylori-triggered HIF-1α
induction and G0/G1 cell cycle arrest in infected gastric
cells.
METHODS
Cell Lines and Culture Conditions
The gastric cancer cell lines AGS (ATCC CRL-1793), MKN74
(JCRB0255), and KATO III (ATCC HTB-103) were cultured
in RPMI 1640 medium (Gibco) supplemented with 10%
Fetal Bovine Serum (Biological Industries) and antibiotics
(10,000 U/ml penicillin, 10µg/ml streptomycin). Cells
were incubated at 37◦C in a humidified atmosphere with
5% CO2.
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H. pylori Strain and Culture Conditions
The completely sequencedH. pylori 26695 (ATCC 700392) strain
was cultured in trypticase soy agar plates supplemented with 5%
horse serum (Biological Industries), nutritive supplement Vitox
(Oxoid) and selective supplement Dent (Oxoid) for 24 h at 37◦C
in a humidified atmosphere with 5% CO2.
Transfection of AGS Cells
AGS cells were transfected with sh-RNA-Scramble plasmid
(Santa Cruz Biotechnology #108065) or sh-RNA-HIF-1α plasmid
(Santa Cruz Biotechnology #35561) using the reagent Fugene 6 R©,
following instructions provided by the manufacturer (Promega,
Madison, WI). Post-transfection, cells were grown in a selection
medium containing 2µg/ml puromycin for 2 weeks. Then,
clones were isolated from batch-transfected cell populations
in order to obtain cells with improved silencing of HIF-1α.
A clone with effective silencing of HIF-1α (AGS sh-HIF-1α
Clone7) and control clone (AGS sh-Scr Clone2) were selected
(see Supplementary Figure 5) and used to perform the indicated
experiments.
Infection of Gastric Cells with H. pylori
8 × 105 cells were seeded in 60mm culture plates and cultivated
for 24 h. For infection assays, culture media was replaced by
serum supplemented RPMI without antibiotics at least 4 h prior
to bacterial exposure. The bacteria were harvested, washed, and
resuspended in PBS. OD560 = 0.4 was considered equivalent to
3×108 bacteria. Cells were infected at themultiplicity of infection
(MOI) indicated in each experiment.
Preparation of Protein Extracts
To obtain the total protein extracts, cells were lysed with
a buffer containing 20mM HEPES pH 7.4, 12.5µg/ml
leupeptin, 10µg/ml antipain, 100µg/ml benzamidine, 1mM
phenylmethylsufonyl fluoride, 1mM sodium orthovanadate and
10mM sodium fluoride, 0.1% SDS, 0.05% NP-40 (IGEPAL).
Then, lysates were sonicated and centrifuged. The resulting
supernatants, referred to as total protein extracts, were stored at
−20◦C.
Nuclear and the cytoplasmatic fractions were essentially
obtained as previously described (Valenzuela et al., 2014).
Briefly, cells were lysed in a hypotonic buffer containing 10mM
Hepes-KOH pH 7.9, 2mM MgCl2, 0.1mM EDTA, 10mM KCl,
0.5% NP-40 (IGEPAL) and supplemented with 1mM DTT,
as well as protease and phosphatase inhibitors (12.5µg/ml
leupeptin, 10µg/ml antipain, 100µg/ml benzamidine, 1mM
phenylmethylsufonyl fluoride, 1mM sodium orthovanadate and
10mM sodium fluoride). The lysate was centrifuged at 16,000 ×
g to obtain the cytoplasmic protein fraction in the supernatant
and the nuclear protein fraction in the pellet. The nuclear pellet
fraction was solubilized in a hypertonic buffer containing 50mM
Hepes-KOH pH 7.9, 2mM MgCl2, 0.1mM EDTA, 50mM KCl,
400mM NaCl, 10% glycerol, supplemented with 1mM DTT, as
well as the protease and phosphatase inhibitors indicated above.
The resulting lysate was centrifuged at 16,000 × g to obtain the
nuclear proteins in the supernatant.
Western Blot Analysis
Proteins (50–75µg total per lane) were separated in 10%
SDS polyacrylamide gels and transferred to a nitrocellulose
membrane, as previously described (Valenzuela et al., 2010).
Blots were blocked with 5% milk in 0.1%-Tween20 TBS or 5%
BSA in 0.1%-Tween20 TBS for phosphorylated proteins. Then,
blots were probed with either mouse anti-HIF-1α monoclonal
antibody (BD Bioscience #610958, dilution 1:500), mouse
anti-β-actin monoclonal antibody (Sigma #A5316, dilution
1:20,000), rabbit anti-phospho-S473-Akt polyclonal antibody
(Cell Signaling Biotechnology #4060, dilution 1:1,000), rabbit
anti-Akt polyclonal antibody (Cell Signaling Biotechnology
#9272, dilution 1:1,000), mouse anti-Cyclin D1 monoclonal
antibody (Santa Cruz Biotechnology #20044, dilution 1:1,000),
rabbit anti-phospho-S235/236-S6 polyclonal antibody (Cell
Signaling #48585, dilution 1:1,000), mouse anti-S6 monoclonal
antibody (Cell Signaling Biotechnology #2317, dilution 1:1,000),
mouse anti-LAP2A monoclonal antibody (BD Bioscience
#611000, dilution 1:3,000) or rabbit anti-HSP90 polyclonal
antibody (Santa Cruz Biotechnology #7947, dilution 1:3,000).
Primary antibodies were detected with horseradish peroxidase-
conjugated anti-mouse (Kirkergaard and Perry Laboratories
#214-1806, dilution 1:5,000) or anti-rabbit (Kirkergaard and
Perry Laboratories #214-1516, dilution 1:5,000) secondary
antibodies and the ECL system.
Protein levels were essentially quantified as previously
described (Valenzuela et al., 2013) by scanning densitometric
analysis of Western blots using the software UnScan-it v. 6.1.
Values obtained for the respective proteins of interest (HIF1a,
Cyclin D1) were standardized to β-actin levels in the same lane.
Results shown in graphs are averages from at least three different
experiments with their respective standard errors of mean (SEM).
Luciferase Reporter Assay
To analyze the HIF-1α transcriptional activity, 1.5 × 105 cells
were transfected with 0.25µg of the respective plasmids: pGL3-
HRE (HIF-1α reporter kindly provided by Dr. Kaye Williams,
University of Manchester (Brown et al., 2006) and pON (β-
galactosidase). Post-transfection, after 16 h, culture media was
replaced by supplemented RPMI 1640 without antibiotics for
inoculation with bacteria. After infection, cells were lysed in a
buffer containing 0.1M KH2PO4 (pH 7.9), 0.5% Triton X-100,
and 1mM DTT. The resulting lysate was centrifuged at 1640 ×
g and supernatants were used to measure either luciferase or
β-galactosidase activities. Luciferase activity was detected using
a luminometer (Synergy HT Multi-Mode Microplate reader,
BioTek Instruments, Winooski, VT) after addition of KTME
buffer containing 100mM Tris HCl, 10mM MgSO4, 2mM
EDTA, 5mM Na2ATP, and 0.1mM luciferin. β-galactosidase
activity was determined by spectrophotometry (410 nm) after
addition of substrate 2-nitrophenyl-β-D-galactopyranoside
(ONPG). The values reported for luciferase activity were
standarized to β-galactosidase activity.
Analysis of mRNA Levels by Real Time
Reverse Transcription PCR
Total RNA was isolated with the reagent TriZOL R© following
instructions provided by the manufacturer. RNA samples were
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spectrophotometrically quantified, digested with DNAse I and
characterized by electrophoresis in 2% agarose gels (quality
control) and then used as templates to generate cDNA.
The real-time quantitative PCR (qPCR) analysis was
performed using the Brilliant II SYBR R© Green QPCR
Master Mix (Agilent Technologies, La Jolla, CA), cDNA
template and the following primers: VEGFA: sense primer
5′-ATCCGGGTTTTATCCCTCTTC-3′ and anti-sense primer
5′-TCTCTCTGGAGCTCTTGCTA-3′; GLUT-1: sense primer
5′- AAGGAAGAGAGTCGGCAGAT-3′ and anti-sense primer
5- TCGAAGATGCTCGTGGAGTA-3’; Bcl-xL: sense primer 5-
CACTAACCAGAGACGAGACT-3′ and anti-sense primer 5′-
GTCCTGTTCTCTTCCACATC-3′; LDHA: sense primer 5′-
ACGTCAGCAAGAGGGAGAA-3′ and anti-sense primer 5′-
TCTTCCAAGCCACGTAGGT-3′; GAPDH: sense primer 5′-
GCGAGATCCCTCCAAAATCA-3′ and anti-sense primer 5′-
ATGGTTCACACCCATGACGA-3′; Cyclin D1: sense primer
5′-GGTGAACAAGCTCAAGTGGA-3′ and anti-sense primer
5′-GAGGGCGGATTGGAAATGAA-3′; RPS13 housekeeping
gene: sense primer 5′-CTCTCCTTTCGTTGCCTGAT-3′ and
anti-sense primer 5′- TGAAGGAGTAAGGCCCTTCT-3′. The
PCR reactions were carried out using the Agilent Mx3000P
QPCR System (Agilent Technologies, La Jolla, CA) following
suggestions of the manufacturer. The relative gene expression
levels were calculated by the 2−11CT method (Livak and
Schmittgen, 2001). VEGFA, GLUT-1, Bcl-xL, LDHA, GAPDH,
and Cyclin D1 levels mRNA levels were normalized to RPS13
mRNA (housekeeping gene). All data were expressed relative to
values obtained for non-infected cells.
Cell Cycle Analysis
After infection, cells were incubated with 200µg/ml gentamycin
at 37◦C for 1 h to eliminate adherent bacteria. Then, cells were
washed, harvested and fixed in chilled methanol at −20◦C for
10min. Fixed cells were treated with 100µg/ml RNAase A for
30min and then stained with 10µg/ml propidium iodide. Cells
were analyzed by flow cytometry (FACS Canto, BD) and the
DNA content was quantified as propidium iodide fluorescence
intensity histograms using the FACSDiva program version 6.1.3.
PI3K/Akt/mTOR, Protein Synthesis, and
Proteasome Inhibitors
The PI3K inhibitor LY294002 (Enzo Life Science #BML-ST420-
005) was used at concentrations of 1, 5 and 10µM; the Akt
inhibitor VIII (Calbiochem #124018) was used at 1µM and
the mTOR inhibitor Rapamycin (Sigma #R8781) at 50 nM. The
inhibitors were added to culture media 30min previous to
infection. All inhibitors were solubilized in DMSO.
To determine the Cyclin D1 half-life, the protein synthesis
inhibitor cycloheximide (CHX) 100µg/ml (Sigma #C0934) was
added to infected cells after 8 h of exposure to H. pylori and
protein extracts were then prepared at the indicated time points
after CHX addition.
To determine the role of the proteasome in Cyclin D1
decrease, the proteasome inhibitor MG132 (20µM) (Enzo Life
Science #BML-PI102-005) was added to infected cells after 8 h
of infection, in the absence and presence of protein synthesis
inhibitor CHX, for 15min. Then, protein extracts were prepared
for western blot analysis.
Statistical Analysis
Results from at least 3 independent experiments were analyzed
by applying 1-way ANOVA analysis and Dunnett post-test to
compare multiple conditions or Student’s t-test to compare
two conditions, using the GraphPad Prism software (GraphPad
Software, San Diego, CA). P < 0.05 was considered significant.
RESULTS
H. pylori Promotes Transient HIF-1α
Induction
Previously, H. pylori infection of gastric cells has been linked
to HIF-1α induction via ROS-dependent mechanisms, VEGF
production and angiogenesis (Park et al., 2003; Bhattacharyya
et al., 2010; Kang et al., 2014). However, alternative pathways
reportedly also contribute toHIF-1α induction in normoxia, such
as activation of PI3K/Akt. Here we evaluated the possibility that
PI3K/Akt activation by H. pylori might favor HIF-1α induction
and sought to identify the cell responses associated with HIF-1
activation. To this end, AGS cells were infected with H. pylori
26695 at MOI 100 and the induction of HIF-1α protein levels,
as well as its intracellular localization were evaluated by western
blotting following infection. HIF-1α protein levels increased
until 8 h, but then decreased to essentially basal levels after
16 h of H. pylori exposure (Figure 1A). Consistent with this, the
nuclear localization of HIF-1α, analyzed by nucleus/cytoplasm
fractionation, increased after 8 h, but then decreased at 24 h post-
infection (Figure 1B). Similar results were obtained by indirect
immunofluorescence analysis of HIF-1α subcellular localization
(Supplementary Figure 1). Likewise, H. pylori-induced HIF-1α
expression also was observed in MKN74 and KATO III gastric
cells infected for 8 h, albeit to varying extents (Supplementary
Figure 2). We then determined whether HIF-1α induction
and translocation to the nucleus were linked to enhanced
transcriptional activity, using a luciferase reporter assay. In AGS
cells infected with H. pylori a MOI-dependent increase in HIF-1
reporter activity was observed after 8 h (Figure 1C).
PI3K Activity Is Necessary for
H. pylori-Induced Akt Activation
H. pylori infection has been linked to PI3K/Akt activation, which
regulates many cellular responses, such as cell cycle progression
and proliferation (Nakayama et al., 2009; Suzuki et al., 2009;
Tabassam et al., 2009). In normoxia, activation of this pathway
downstream of growth factor receptors can induce HIF-1α. Thus,
we wondered whether a similar connection might exist following
H. pylori infection. To that end, the levels of p-Ser473-Akt were
evaluated as an indicator of PI3K activity at different time points
following infection with H. pylori. For AGS cells infected with
H. pylori 26695 at MOI 100, a substantial increase in p-Ser473-
Akt levels was detected after 4 and 8 h of infection, which then
decreased 16 and 24 h post-infection (Figure 2A). These changes
paralleled those observed for HIF-1α protein levels following H.
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FIGURE 1 | H. pylori promotes transient HIF-1α induction, nuclear localization and transcriptional activity. (A) AGS cells were infected with H. pylori 26695
at MOI 100 for time periods indicated. The levels of HIF-1α and β-actin were analyzed by western blotting. The relative levels of HIF-1α were determined (mean ±
SEM; n = 4, *p < 0.05; **p < 0.01). (B) AGS cells were infected with H. pylori 26695 at MOI 100 for time periods indicated and then cytoplasmic and nuclear
fractions were obtained. The levels of HIF-1α, HSP90 (cytoplasmic marker) and LAP2 (nuclear marker) were analyzed by western blotting. The relative nuclear levels of
HIF-1α were determined (mean ± SEM, n = 4; **p < 0.01). (C) AGS cells were co-transfected with the pGL3-HRE-luciferase and pON-β-galactosidase plasmids and
then were infected with H. pylori at the indicated Multiplicity of Infection (MOI) for 8 h. The cells were lysed and the luciferase and β-galactosidase activities were
determined. The luciferase activity was standarized to the β-galactosidase activity (mean ± SEM; n = 4; *p < 0.05; ***p < 0.001).
pylori infection (Figure 1A). Thus, PI3K/Akt activation and HIF-
1α induction occurred with similar kinetics following H. pylori
infection.
PI3K Inhibition Precludes H. pylori-Induced
HIF-1α Expression
To evaluate whether HIF-1α induction was due to PI3K
activation, cells were incubated with LY294002, a selective
pharmacological inhibitor of PI3K. In AGS cells infected by H.
pylori, LY294002 (at 5 and 10µM) reduced significantly HIF-1α
induction observed 4 and 8 h post-infection (Figures 2B,C,
respectively). Under these conditions, LY294002 prevented
PI3K activation by H. pylori, since phosphorylation of Akt S473
was almost completely abolished (Figures 2B,C). Alternatively,
the adhesion of H. pylori to gastric cells was not altered in the
presence of the PI3K inhibitor (Supplementary Figures 3A,B),
suggesting that the observed results with HIF-1α were not
attributable to non-specific effects of the inhibitor on the
bacterial adherence to AGS cells. In addition, infection in the
presence of the PI3K inhibitor did not affect the translocation
of virulence factors to the host cells, since intracellular protein
levels of CagA, a virulence factor secreted by the bacteria
into the host cell, was not modified by PI3K inhibition
(Supplementary Figure 4A). Also, immunoprecipitation
of intracellular CagA showed that phosphorylation on
tyrosine of CagA, which occurs intracellularly, was not
affected by presence of the PI3K inhibitor (Supplementary
Figure 4B).
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FIGURE 2 | The inhibition of PI3K precludes the H. pylori-promoted HIF-1α induction. (A) AGS cells were infected with H. pylori 26695 at MOI 100 for time
periods indicated. The levels of p-S473-Akt, total Akt and β-actin were analyzed by western blotting. The relative levels of p-S473-Akt were determined (mean ± SEM;
n = 4; *p < 0.05; **p < 0.01). (B,C) AGS cells were pre-treated with LY294002 (1, 5, and 10µM) for 30min and then infected with H. pylori 26695 at MOI 100 for 4 h
(B) or 8 h (C). The levels of HIF-1α, p-S473-Akt, Akt, and β-actin were analyzed by western blotting. The relative levels of HIF-1α/β-actin were determined (mean ±
SEM; n = 3–4, ***p < 0.001).
mTOR Inhibition Precluded
H. pylori-Promoted HIF-1α Induction
In fibroblasts, as well as breast and colon cancer cells, stimuli
leading to PI3K activation increase HIF-1α protein levels through
the downstream activation of Akt and mTOR (Laughner et al.,
2001; Fukuda et al., 2002). To determine which elements
downstream of PI3K were required for H. pylori-mediated
HIF-1α induction, cells were incubated with the mTOR inhibitor
Rapamycin (50 nM) during infection by 4 h or 8 h and mTOR
inhibition was assessed by determining the levels of S6
phosphorylation on S235/236 (p-S235/236-S6) due to S6K, a
direct target of mTOR (Semenza, 2012). Indeed, Rapamycin
for either 4 h or 8 h effectively inhibited mTOR activity and
precluded the H. pylori-induced HIF-1α protein levels in
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FIGURE 3 | The inhibition of mTOR precludes the H. pylori-promoted HIF-1α induction while Akt inhibition is only partially effective. (A,B) AGS cells
were pre-treated with Rapamycin (50 nM) for 30min and then infected with H. pylori 26695 at MOI 100 for 4 h (A) or 8 h (B). The levels of HIF-1α, p-S235/236-S6, S6,
and β-actin were analyzed by western blotting. The relative levels of HIF-1α were determined (mean ± SEM; n = 3–4; ***p < 0.001). (C,D) AGS cells were pre-treated
with Akt inhibitor (1µM) for 30min and then infected with H. pylori 26695 at MOI 100 for 4 h (C) or 8 h (D). The levels of HIF-1α, p-S473-Akt, total Akt, and β-actin
were analyzed by western blotting. The relative levels of HIF-1α were determined (mean ± SEM; n = 3.4, *p < 0.05; ***p < 0.001).
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FIGURE 4 | Effect of H. pylori infection on HIF-1α target gene expression. AGS cells were infected with H. pylori 26695 at MOI 100 for 8 h and 24 h. mRNA
levels of GLUT-1 (A), LDHA (B), GAPDH (C), Bcl-xL (D), and VEGFA (E) were evaluated by RT-qPCR. The levels of each mRNA were normalized to RNA of the RPS13
housekeeping gene. All data were expressed relative to values obtained for time 0 h of infection (mean ±SEM; n = 3–4; *p < 0.05).
AGS cells (Figures 3A,B, respectively). Again, as a control,
Rapamycin (50 nM) was shown neither to affect H. pylori
adhesion to AGS cells (Supplementary Figure 3C,D), or the
phosphorylation of immunoprecipitated CagA (Supplementary
Figure 4C). Interestingly, the Akt inhibitor (1µM) was not
significantly effective in reducing HIF-1α induction following 4
or 8 hH. pylori infection (Figures 3C,D, respectively), suggesting
that mTOR activation downstream of PI3K is the major pathway
responsible for HIF-1α induction following H. pylori infection.
H. pylori Infection Does Not Change HIF-1α
Target Gene Expression
Since our results showed an increase in the nuclear localization
of HIF-1α and an increase in the reporter activity after 8 h
of infection by H. pylori (Figures 1B,C), we next evaluated
whether some of the known target genes of HIF-1α were
induced byH. pylori infection. Unexpectedly,H. pylori promoted
only few and rather modest changes in the mRNA levels of
known downstream target genes of HIF-1α. Specifically, GLUT-1,
LDHA, and GAPDH did not change, while for Bcl-xL a trend but
not a significant increase was observed (Figure 4). This suggested
to us that HIF-1α induction following H. pylori infection may be
more closely linked to non-canonical functions.
Thus, to determine whether HIF-1α was required to increase
transcription of the indicated genes, we also isolated clonal
populations of AGS cells in which HIF-1α had been silenced.
AGS cells were transfected with sh-RNA that specifically silenced
HIF-1α expression or with a sh-RNA Scramble as a control and
then infected with H. pylori. To evaluate the efficiency of the
HIF-1α silencing, stably transfected cells were treated with the
chemical inducer of HIF-1α, Deferroxamine (DFO) (200µg/ml),
and the levels of HIF-1α were determined by western blotting
(Supplementary Figure 5). The stably transfected clones AGS sh-
HIF-1α C7 and AGS sh-Scr C2 were chosen for infection by
H. pylori 26695 at MOI 100 for 24 h and induction of mRNA
of several HIF-1α target genes were evaluated. In these AGS
sh-Scr C2 (clonal control) cells, some differences with respect
to the wild-type cells were noted. For instance, we observed
modest changes in the mRNA levels of GLUT-1 after 24 h of
H. pylori infection. Importantly, however, similar changes were
also detected in sh-HIF-1α C7 cells lacking HIF-1α, indicating
that they were HIF-1α-independent. For LDHA, aminor increase
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FIGURE 5 | Effect of HIF-1α silencing on gene induction in response to H. pylori infection. AGS sh-Scr C2 and sh-HIF-1α C7 cells were infected with H. pylori
26695 at MOI 100 for 8 and 24 h. mRNA levels of GLUT-1 (A), LDHA (B), VEGFA (C), and HIF-1α (D) were evaluated by RT-qPCR. The levels of each mRNA were
normalized to RNA of the RPS13 housekeeping gene. All data were expressed relative to values obtained for time 0 h of infection in sh-Scr cells (mean ± SEM;
n = 3–4, *p < 0.05; **p < 0.01; ***p < 0.001).
was observed after 8 h of bacterial infection in cells expressing
HIF-1α. However, overall a trend toward decreased LDHA was
detectable after 24 h both in the cells expressing or lacking
HIF-1α (Figure 5). Moreover, for VEGFA substantially elevated
expression was noticeable after 24 h, but again these changes
were seen in cells expressing or not HIF-1α (Figure 5). Taken
together, these results suggested that the increase in nuclear
HIF-1α protein levels and reporter activity (Figures 1B,C,
respectively) was likely to be associated with additional
functions beyond the transcriptional activation of common target
genes.
H. pylori Induces G0/G1 Cell Cycle Arrest
in Gastric Cells
Although H. pylori promotes activation of signaling pathways
linked to cell cycle progression and proliferation (Suzuki et al.,
2009), the bacteria is also known to induce G1 cell cycle arrest
(Shirin et al., 1999; Ahmed et al., 2000). To evaluate in our hands
how H. pylori modulates the cell cycle, AGS cells were infected
with the bacteria at MOI 100 for 24 h. This time point was
chosen post-infection considering that it represented roughly the
amount of time necessary to complete one cycle of duplication.
Then, cell cycle distribution was analyzed by flow cytometry. As
is shown (Figure 6), infection increased the number of cells in
G0/G1 and decreased the number of cells in G2/M compared to
non-treated cells. Alternatively, the number of cells in S phase
was not significantly altered by infection.
HIF-1α Silencing Prevents G0/G1 Cell
Cycle Arrest Promoted by H. pylori in
Gastric Cells
Our observations shown in Figure 5 indicated that HIF-1α
induction by H. pylorimay be triggering an alternative response,
not necessarily linked to an increase in the expression of specific
genes. Indeed, in more recent years, a non-canonical role for
HIF-1α, independent of its transcriptional activity, has emerged,
involving the inhibition of DNA replication and promotion of G1
cell cycle arrest (Huang, 2013). To test whetherH. pylori- induced
HIF-1α is able to induce cell cycle arrest, the stably transfected
clones AGS sh-HIF-1α C7 and AGS sh-Scr C2 were infected by
H. pylori 26695 atMOI 100 for 24 h and cell cycle distribution was
determined by flow cytometry. We observed that infection with
H. pylori increased the percentage of cells in the G0/G1 phase in
sh-Scr C2 AGS cells (Figures 7A–C), while the percentage of cells
in S phase increased in sh-HIF-1α C7 AGS cells (Figures 7–C).
Moreover, infection decreased the percentage of both control
cells and HIF-1α knockdown cells in G2/M phase to the same
extent (Figures 7–C). Taken together, these data suggest that H.
pylori-induced HIF-1α prevents G1/S cell cycle progression, but
does not affect transition to the G2/M phase.
HIF-1α Knockdown Reduces
H. pylori-Induced Loss of Cyclin D1 Protein
Cyclin D1 is required for progression of cells through the G1
phase of the cell cycle, and decreased expression has been
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FIGURE 6 | H. pylori infection increases cells in G0/G1 phase and decreases cells in G2/M phase of cell cycle. AGS cells were infected with H. pylori 26695
at MOI 100 for 24 h and cell cycle distribution was determined by flow cytometry. (A) Representative profiles of the cell cycle distribution are shown for the indicated
conditions. (B) Percentage of cells in each phase of the cell cycle phase are summarized (mean ± SEM, n = 4; *p < 0.05).
linked to an arrest in this phase (Malumbres, 2011). To evaluate
whether HIF-1α modulated Cyclin D1 levels and promoted
cell cycle arrest in G0/G1 phase, sh-HIF-1α C7 and sh-Scr C2
AGS cells were infected with H. pylori for 8 and 24 h and
Cyclin D1 levels were measured. We observed that Cyclin D1
protein levels decreased in both cell lines after 24 h of infection;
however, for HIF-1α knockdown cells, Cyclin D1 levels were
higher compared to control cells at this time point of infection
(Figure 8A), suggesting that HIF-1α contributes to the decrease
in Cyclin D1 triggered by H. pylori infection and cell cycle
arrest. To evaluate whether the decrease in Cyclin D1 protein
levels mediated by H. pylori-induced HIF-1α was attributable to
a transcriptional mechanism, the Cyclin D1 mRNA in sh-HIF-
1α C7 and sh-Scr C2 AGS cells infected with H. pylori were
determined. Our results revealed that infection did not reduce
the transcription of Cyclin D1 in either of the stably transfected
cell lines. If anything, a tendency toward increased expression
was observed 24 h post-infection by H. pylori, and this trend
was similar for cells expressing or not HIF-1α (Figure 8B). To
analyze whether H. pylori-induced HIF-1α affected Cyclin D1 at
the post-translational level, sh-HIF-1α C7 and sh-Scr C2 AGS
cells were infected byH. pylori for 8 h, treated with cycloheximide
(CHX) to block the protein synthesis and then the kinetics of
Cyclin D1 protein loss were determined. As shown in Figure 8C,
Cyclin D1 protein levels declined more rapidly for the sh-Scr C2
than for sh-HIF-1α C7 AGS cells. Protein half-life was found to
be approximately 9min (t1/2 = 9min) in sh-Scr C2 AGS cells,
compared to the 20min (t1/2 = 20min) for sh-HIF-1α C7 cells.
These results suggest thatH. pylori-inducedHIF-1α promotes the
decline in Cyclin D1 by a post-translational mechanism.
Finally, to determine whether the proteasome pathway is
involved in this mechanism, AGS cells infected with H. pylori
for 8 h were treated with CHX together with MG132, a specific
proteasome inhibitor. Our results showed that infection in the
presence of MG132 and CHX partially restored Cyclin D1
levels compared to the treatment with CHX alone (Figure 8D),
suggesting that Cyclin D1 decrease mediated by H. pylori
infection is attributable in part to degradation via the proteasome.
This recovery is apparently more effective in AGS sh-HIF-1α C7
cells; however, the degree of recovery (expressed in percent) in
Cyclin D1 in the presence of MG132 is similar for both AGS sh-
Scr C2 and sh-HIF-1α C7 cells (Figure 8D). This can be taken to
suggest that the presence of HIF1α does not alter proteasome-
mediated turnover, but rather some other post-translational
process.
DISCUSSION
The infection with H. pylori has been associated with seemingly
contradictory responses in human gastric samples and in vitro
studies. While infection with the bacteria reportedly activates
proliferative and anti-apoptotic signaling, also apoptosis and cell
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FIGURE 7 | The lack of HIF-1α promotes the transition from G1 to S
phase of the cell cycle in gastric cells infected with H. pylori. Stably
transfected AGS sh-Scr C2 and AGS sh-HIF-1α C7 cells were infected with
H. pylori 26695 at MOI 100 for 24 h and cell cycle distribution was determined
by flow cytometry. (A) Representative cell cycle distribution profiles for the
indicated conditions. (B) Percentage of cells in each phase of the cell cycle are
summarized (mean ± SEM, n = 4; *p < 0.05; **p < 0.01) (C) Changes
following infection in the percentage of cells in each phase of the cell cycle are
summarized graphically (mean ± SEM, n = 4; *p < 0.05).
cycle arrest have been observed (Shirin et al., 1999; Ahmed et al.,
2000; Nagy et al., 2009; Suzuki et al., 2009; Tabassam et al.,
2009; Valenzuela et al., 2010, 2013). In the present study, HIF-
1α was identified as a molecular linker between proliferative and
anti-proliferative effects, since activation of PI3K/mTOR, a well-
established proliferative and survival pathway, followingH. pylori
infection, lead to increased HIF-1α expression, which in turn
promoted G0/G1 cell cycle arrest in gastric cells.
H. pylori-mediated HIF-1α induction is generally attributed
to oxidative stress produced by the bacteria in gastric cells
(Park et al., 2003; Bhattacharyya et al., 2010; Kang et al., 2014).
Here, however, we showed that HIF-1α induction was due to H.
pylori-induced PI3K/mTOR activation. Both mechanisms are not
exclusive, but rather may be complementary, considering that
oxidative stress activates many kinases, including PI3K (Schieber
and Chandel, 2014). Indeed, we have previously reported on
the possible role of reactive oxygen species produced due to
liberation of gamma glutamyl transpeptidase (GGT) by the
bacteria in down-regulation of Survivin following infection of
gastric cells (Valenzuela et al., 2013). In those studies, we
generated an H. pylori strain lacking GGT activity (1ggt) and
observed that such bacteria failed to induce the formation of
reactive oxygen species upon infection of recipient gastric cells.
Interestingly, however, 1ggt H. pylori were still able to induce
HIF-1α upon infection of cells (data not shown). Thus, additional
experiments will be necessary to determine how PI3K is activated
during H. pylori infection.
Our studies showed that H. pylori-induced PI3K/Akt
activation is transient, occurs relatively early on following
infection and follows kinetics similar to those observed for HIF-
1α induction. As anticipated, inhibition of PI3K completely
abolished HIF-1α induction; however, rather unexpectedly,
experiments using the Akt inhibitor (Akti) were not effective,
while the mTOR inhibitor Rapamycin emerged as being more
relevant in this respect. Indeed, in a melanoma cell model PI3K
inhibition was recently shown to prevent the activation of mTOR
and cellular proliferation, but Akt inhibition did not lead to the
same effect (Silva et al., 2014). These reported findings together
with our own observations support the notion that mTOR
activationmay occur downstream of PI3K in anAkt-independent
manner.
In vitro studies have demonstrated that both cell cycle
progression and cell cycle arrest are favored following H. pylori
infection. However, there are notable temporal differences: while
infection tends to favor cell cycle progression early on, G1
cell cycle arrest and apoptosis are often the consequence at
later stages of infection (Peek et al., 1999; Shirin et al., 1999).
Consistent with this interpretation, our studies showed that
PI3K/Akt activation occurs relatively rapidly post-infection,
but then cell cycle arrest was observed later on. Interestingly,
however, HIF-1α also was induced at early times of infection,
but participates as shown here in H. pylori-mediated inhibition
of the G1/S transition, indicating that infection-induced G0/G1
cell cycle arrest is not a late event, but rather a phenomenon
that is initiated early on post-infection. The importance of our
findings resides in showing that HIF-1α, a protein normally
associated with survival responses, particularly downstream of
PI3K activation, participates in the transition to cell cycle arrest.
Beyond the HIF-1α-mediated arrest in G1/G0 phase following
infection, the percentage of cells in G2/M phase decreased,
suggesting that additional effects of H. pylori on the cell cycle
occur in a manner independent of HIF-1α. Indeed, alterations
in the G2/M phase may be related to the decrease in expression
of the anti-apoptotic protein Survivin following H. pylori
infection, as we previously reported (Valenzuela et al., 2010,
2013). However, Survivin reduction is not likely linked to HIF-
1α in our experimental conditions, because HIF-1α would be
expected to promote transcription of BIRC5 (Survivin) and
other genes (Peng et al., 2006; Semenza, 2012). None-the-
less, despite increased reporter activity (Figure 1C), we only
observed relatively modest increases in target gene expression
(see Figure 4) that were largely independent of HIF-1α induction
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FIGURE 8 | The lack of HIF-1α partially attenuates H. pylori-enhanced Cyclin D1 decline by a post-translational mechanism. (A) Stably transfected AGS
sh-Scr C2 and AGS sh- HIF-1α C7 cells were infected with H. pylori 26695 at MOI 100 for 8 and 24 h. The levels of Cyclin D1, HIF-1α, and β-actin were analyzed by
western blotting. The relative levels of Cyclin D1 were determined (mean ±SEM, n = 4; *p < 0.05; **p < 0.01). (B) Stably transfected AGS sh-Scr C2 and AGS sh-
HIF-1α C7 cells were infected with H. pylori 26695 at MOI 100 for 8 and 24 h. mRNA levels of Cyclin D1 were evaluated by RT-qPCR. The levels of Cyclin D1 mRNA
were normalized to RNA levels of RPS13, employed here as a housekeeping gene. Data were expressed relative to values obtained for time 0 h of infection (mean ±
SEM, n = 4; **p < 0.01; ***p < 0.001). (C) Stably transfected AGS sh-Scr C2 and AGS sh-HIF-1α C7 cells were infected with H. pylori 26695 at MOI 100 for 8 h and
then treated with cycloheximide (100µg/ml) for the time points indicated. The levels of Cyclin D1 and β-actin were analyzed by western blotting. The relative levels of
Cyclin D1 were determined (mean ± SEM, n = 3). (D) Stably transfected AGS sh-Scr C2 and AGS sh-HIF-1α C7 cells were infected with H. pylori 26695 at MOI 100
for 8 h and then cycloheximide (CHX) (100µg/ml) and/or MG132 (20µM) were added. Cells extracts were collected after 15min of these treatments. Cyclin D1 and
β-actin levels were evaluated by western blotting. The relative levels of Cyclin D1 were determined (mean ± SEM, n = 4; *p < 0.05; **p < 0.01; ***p < 0.001).
(Figure 5). Likewise, loss of Survivin expression following H.
pylori infection was similar after 24 h in AGS cells expressing or
not HIF-1α (data not shown). Taken together, these observations
suggest that H. pylori-induced Survivin decline may not only
promote apoptotic cell death, but also decrease the number of
cells in the G2/M phase in a manner independent of HIF-1α.
As indicated above, we previously showed that H. pylori
infection induces apoptosis in infected cells after 24 h
(Valenzuela et al., 2010, 2013) and we corroborated here that
viability decreased by roughly 40–50% under these conditions
(Supplementary Figure 6). Thus, a concern in our studies could
have been the fact that HIF-1α expression peaked 8 h after H.
pylori infection and disappeared subsequently. Specifically, the
apparently non-canonical role documented here for HIF-1α
after 24 h could have been attributed to the fact that induction of
HIF-1α only occured in a fraction of the infected AGS cells and
that those expressing HIF-1α selectively underwent apoptosis
leaving only cells in which HIF-1α expression had never been
induced. This can be considered a highly unlikely possibility for a
number of reasons. First, the multiplicity of infection (MOI 100)
employed was such that all cells should have been infected by the
bacteria. Second, as far as we were able to determine, HIF1α was
induced to a similar extent in most cells after 8 h. Indeed, using
indirect immunofluorescence analysis we found that about 80%
of the nuclei were HIF1α positive (Supplementary Figure 1C),
but viability only decreased by 40–50% after 24 h (Supplementary
Figure 6). Third, loss in viability was the same for sh-Scr C2
and sh-HIF-1α C7 AGS cells (Supplementary Figure 6). Taken
together, these findings make it highly unlikely that we were
selectively eliminating HIF1α expressing cells following infection
with H. pylori and therefore, that the effects observed after 24 h
were not linked to induction of HIF-1α upon H. pylori infection.
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H. pylori-induced HIF-1α expression is associated with
increased expression of Mcl-1, VEGF and Lon protease, via
a transcriptional mechanism (Bhattacharyya et al., 2010; Kang
et al., 2014; Luo et al., 2016). However, in our hands, we found
little evidence for enhanced transcription of typical target genes
due to HIF-1α (see Figures 4, 5), despite the notable increase in
HIF-1α protein levels and reporter activity (Figure 1C). Thus,
our results favor the notion that the G0/G1 cell cycle arrest due
to HIF-1α induction is part of a non-transcriptional mechanism,
as has been suggested in other experimental contexts (Goda
et al., 2003; Koshiji et al., 2004; Hubbi et al., 2013). Although
HIF-1α reportedly is pro-carcinogenic, it was found here to
promote cell cycle arrest, which may potentially be relevant in
early steps of gastric cancer development (Xia and Talley, 2001).
Together, these observations suggest that HIF-1α reduces the
proliferation that would be necessary to offset apoptosis seen also
under our experimental conditions (see Supplementary Figure 6).
These observations may be relevant to those known to occur
in the gastric epithelium following H. pylori infection and the
development of pre-neoplastic lesions in atrophic gastritis (Xia
and Talley, 2001; Correa and Houghton, 2007).
Previous studies have suggested that H. pylori infection
induces the expression of Cyclin D1 via activation of themitogen-
activated protein kinase (MAPK) pathway (Hirata et al., 2001).
Consistent with these findings, we did see a trend toward
increased Cyclin D1 mRNA levels that became statistically
significant in those cells where HIF-1α had been knocked
down using specific shRNA constructs after 24 h of infection
(Figure 8B). Despite this increase, Cyclin D1 protein levels
decreased, likely due to enhanced protein degradation as is
suggested by the notable decline in Cyclin D1 protein half-
life in sh-Scr C2 AGS cells compared to that of the sh-HIF-
1α C7 cells lacking HIF-1α (see Figure 8). Cyclin D1 activates
Cdk4 and Cdk6, both of which are important in cell cycle
progression through the G1 phase, and reduced Cyclin D1
expression impedes the G1/S transition (Malumbres, 2011).
Thus, the observed G1/G0 cell cycle arrest attributable here to
theH. pylori-induced HIF-1α increase is likely to reflect the more
rapid decrease in Cyclin D1 protein (reduced protein half-life) in
cells expressing HIF-1α.
Cyclin D1 protein levels reportedly decrease following insult
by genotoxic agents (Alao, 2007) and H. pylori has been shown
to induce DNA damage (Toller et al., 2011). Moreover, HIF-
1α has been suggested to favor genomic instability by inhibiting
proteins necessary for DNA repair in a manner independent
of its transcriptional activity (Koshiji et al., 2005; Yoo et al.,
2011). These mechanisms would provide an explanation for
previous studies showing that HIF-1α induction following H.
pylori infection results in DNA damage, which in turn would
be expected to reduce Cyclin D1 levels, as observed in our
experiments. However, in our hands we were unable to detect
any significant differences in DNA damage, as assessed by the
comet assay, following H. pylori infection of cells expressing or
not HIF-1α (see Supplementary Figure 7).
HIF-1α reportedly prevents Cyclin D1 expression by binding
to the promoter region of the gene (Wen et al., 2010). Consistent
with this possibility, we did observe that HIF-1α silencing
FIGURE 9 | Proposed working model. H. pylori infection promotes the
activation of PI3K and subsequently, of mTOR. The activation of this pathway
increases the levels of HIF-1α, a protein mainly present in the nucleus. H.
pylori-induced HIF-1α decreases the Cyclin D1 levels by a post-translational
mechanism. Cyclin D1 is a protein necessary for G1 phase progression.
Therefore, its reduction affects the normal progression of the cell cycle,
promoting an arrest in G1 phase. Gray boxes: Inactive protein kinases. Green
boxes: Active protein kinases associated with cell cycle progression. Blue
boxes: effects linked to cell cycle arrest. Red boxes: HIF-1α as a switch
between cell cycle progression and cell cycle arrest. Dashed arrows: steps
ocurring by mechanism(s) that were not defined in this study.
augmented Cyclin D1 mRNA after infection (Figure 8B).
However, Cyclin D1 mRNA levels did not decrease in infected
cells expressing HIF-1α, allowing us to rule out the possibility
that HIF-1α reduces Cyclin D1 expression by this transcriptional
mechanism in our model. Instead, Cyclin D1 half-life in the
presence of bacteria was reduced in sh-Scr C2 AGS cells
compared to that of the sh-HIF-1αC7 cells lacking HIF-1α. Thus,
HIF-1α promotes Cyclin D1 decrease by a post-translational
mechanism. Unfortunately, although the proteasome pathway
plays a prevalent role in Cyclin D1 turnover (Alao, 2007), and
also was found to participate in our experimental system, results
obtained with the proteasome inhibitor MG132 indicated that
differences in Cyclin D1 protein half-life in the presence or
absence of HIF-1α were not likely attributable to modulation of
the proteasome pathway.
In conclusion, the results obtained in this study uncover
a novel role for HIF-1α in response to H. pylori infection
of gastric cells, serving to connect an initial early potentially
survival response, downstream of PI3K/mTOR activation, to
G1/G0 cell cycle arrest later on following infection. The sequence
of events is summarized in a tentative working model (Figure 9).
Infection with H. pylori initially triggers PI3K activation, by as
yet undefined mechanisms. Downstream activation of mTOR is
depicted as stabilizing HIF-1α protein, which translocates to the
nucleus, where instead of promoting transcription of target genes
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it participates in destabilizing Cyclin D1 protein and thereby
favoring G1/S cell cycle arrest. Thus, HIF-1α emerges as an
unsuspected linker between cell cycle progression/proliferation
and cell cycle arrest/apoptosis, two seemingly contradictory
effects observed in gastric cells following infection withH. pylori.
Further studies are required to understand theH. pylori–induced
mechanisms that control this switch in HIF-1α function from
a transcription factor that generally is thought to promote cell
survival to a factor that favors cell cycle arrest.
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